ASBPNasdaqPharmaceutical Preparations

Aspire Biopharma Holdings, Inc. (ASBP) earnings date, market-implied expected move, and options open interest by expiry

7.28

−0.02 · −0.34%

post 7.28 0.00%

Closed16:00 ET

Open7.51Volume38,883Mkt cap$10.2M

Day7.12 – 7.9718%52-wk3.31 – 431.881%

ASBP

Aspire Biopharma Holdings, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 12

in 9 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

filed ties

13F top-10 QoQ

—

Top fund weight

—

Aspire Biopharma (ASBP) is expected to report on Nov 12 (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

as filedQ2 FY26

−6116.83%as filednet margin · revenue −26.88% QoQ

Revenue$20,732−26.88%

Gross profit−$30,086−145.12%−623.23%

Operating income−$3M−12918.30%−62.69%

Pre-tax income−$1M+60.65%

Net income−$1M−6116.83%+60.65%

Cost of revenue$50,818+124.83%

Operating expenses$3M+60.31%

Tax$0—

Other income$1M+189.43%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×1.80· ±11.2% vs ±6.2% · 11 releases

eventrelease day|move|up · n×base

PPIproducer prices±11.2%7 of 11×1.80

PCEpersonal income & outlays±8.2%6 of 19×1.31

GDPgross domestic product±8.0%8 of 19×1.28

NFPjobs report±7.8%5 of 10×1.26

CPROFcorporate profits±7.3%7 of 12×1.18

CPIconsumer prices±5.9%4 of 11×0.94

FOMCrate decision±5.8%9 of 23×0.93

Bar = avg |move| to ±12% · tick = ±6.2% avg day · ×base = |move| ÷ ±6.2% · min 6 releases

Earnings history

EPS -1.22 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-1.22	—
Q1 FY26	—	-20.57	—
Q3 FY25	—	-0.04	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod